The spectrum of practice in the diagnosis and management of pneumonia in patients requiring mechanical ventilation. Australian and New Zealand Practice in Intensive Care (ANZPIC II)

Anaesthesia and Intensive Care

Volumn 33, Issue 1, 2005, Pages 87-100

  Boots, R J ^a   Lipman, J ^a   Bellomo, R ^b   Stephens, D ^c   Heller, R F ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b AUSTIN HEALTH   (Australia)

^c ROYAL DARWIN HOSPITAL   (Australia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Pneumonia: ICU, practice

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CIPROFLOXACIN; CYCLOSPORIN; DICLOXACILLIN; IMIPENEM; MACROLIDE; MEROPENEM; METRONIDAZOLE; PENICILLIN G; TIMENTIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ARTIFICIAL VENTILATION; AUSTRALIA; BACTERIUM ISOLATION; BLOOD CULTURE; BRONCHOSCOPY; CHILD; CLINICAL FEATURE; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG USE; FEMALE; FREQUENCY ANALYSIS; HOSPITAL INFECTION; HUMAN; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; OUTCOMES RESEARCH; PNEUMONIA; PRESCRIPTION; PROSPECTIVE STUDY;

EID: 14244262375     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0503300115     Document Type: Article

References (60)

1. Marrie TH, Durant H, Yates L. Community-acquired pneumonia requiring hospitalisation: 5 year prospective study. Rev Infect Dis 1989; 11:586-599.
2. Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisen R, Agusti-Vidal A. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest 1988; 93:318-324.
3. Torres A, Serra-Batlles J, Ferrer A et al. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991; 144:312-318.
4. Stevens RM, Teres D, Skillman JJ, Feingold DS. Pneumonia in an intensive care unit. Arch Inter Med 1974; 134:106-111.
5. Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia: Etiology, prognosis and treatment. Am Rev Respir Dis 1990; 142:369-373.
6. Chastre J, Fagon JY. Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia. Am J Respir Crit Care Med 1994; 150:570-574.
7. Niederman MS, Torres A, Summer W. Invasive diagnostic testing is not needed to routinely manage suspected ventilator associated pneumonia. Am J Respir Crit Care Med 1994; 150:565:569.
8. McCabe JR, Jackson GG. Gram-negative bacteraemia I: etiology and ecology. Arch Intern Med 1962; 110:847-855.
9. Le-Gall JR, Lemeshow S, Saulnier F. A new simplified physiology score (SAPS II) based on a European/North American multicentre study. JAMA 1993; 270:2957-2963.
10. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am J Respir Crit Care Med 1993; 148:1418-1426.
11. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. Am J Respir Crit Care Med 1995; 153:1711-1725.
12. Pingleton SK, Fagon JY, Leeper Jr KV. Patient selection for clinical investigation of ventilator-associated pneumonia: criteria for evaluating diagnostic methods. Chest 1992; 102:553S-556S.
13. Pugin J, Aukenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143:1121-1129.
14. Vincent J-L, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710.
15. Langer M, Cigada M, Mandelli M, Mosconi P, Tognoni G, I.C.U.G.I.C. a. Early onset pneumonia: a multicentre study in intensive care units. Intensive Care Med 1987; 13:342-346.
16. Boots RJ, Lipman J, Bellomo R, Stephens D, Heller R. Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand Practice in Intensive Care (ANZPIC II) Anaesth Intensive Care 2005; 33:101-111.
17. Boots RJ, Lipman J, Bellomo R, Stephens D, Heller R. Predictors of physician confidence to diagnose pneumonia and determine illness severity in ventilated patients. Australian and New Zealand Practice in Intensive Care (ANZPIC II) Anaesth Intensive Care 2005; 33:112-119.
18. Dupont WD, Plummer WD. Power and sample size calculations: a review and computer program. Control Clin Trials 1990; 11:116-128.
19. Hosmer DW, Lemeshow S. Applied Logistic Regression 2nd Edition. New York: John Wiley & Sons Inc, 2000:373.
20. Almirall J, Mesalles E, Klamburg J, Parra O, Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 1995; 107:511-516.
21. Chevret S, Hemmer M, Carlet J, Langer M, European Cooperative Group on Nosocomial Pneumonia. Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicentre prospective study on 996 patients. Intensive Care Med 1993; 19:256-264.
22. Johanson WGJ, Pierce AK, Sandford JP, Thomas GD. Nosocomial respiratory infections with gram negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 1972; 77:701-706.
23. Montravers P, Veber B, Auboyer C et al. Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: Results of the Eole study. Crit Care Med 2002; 30:368-375.
24. Wahl WL, Franklin GA, Brandt M-M et al. Does Broncho-alveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit? J Trauma; 2003; 54:633-639.
25. Ostergaard L, Andersen PL. Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology. Chest 1993; 104:1400-1407.
26. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 2001; 95:78-82.
27. Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R. Bacteremic nosocomial pneumonia. A 7-year experience in one institution. Chest 1995; 108:786-788.
28. Meehan TP, Fine MJ, Krumholz HM et al. Quality of care, process, and outcome in elderly patients with pneumonia. JAMA 1997; 278:2080-2084.
29. Ewig S, Bauer T, Hasper E, Marklein G, Kubini R, Luderitz B. Value of routine microbial investigation in community-acquired pneumonia treated in a tertiary care center. Respiration 1996; 63:164-169.
30. Jackson LM, Shanahan F, Cryan B, Bredin CP, Cronin CC. Appropriateness of laboratory tests: requests for atypical pneumonia serology in a teaching hospital. Ir J Med Sci 1996; 165:93-94.
31. Moine P, Vercken JB, Cheveret S, Gajdos P. Severe community-acquired pneumococcal pneumonia. Scand J Infect Dis 1995; 27:201-206.
32. Fang GD, Fine M, Orloff J et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicentre study of 359 cases. Medicine 1990; 69:307-316.
33. Timsit JF, Chevert S, Valcke J et al. Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. Am J Respir Crit Care Med 1996; 154:116-123.
34. Fine MJ, Stone RA, Singer DE et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team. Arch Intern Med 1999; 159:970-980.
35. Turnidge JD, Bell JM, Collignon PJ. Rapidly emerging antimicrobial resistences in Streptococcus pneumoniae in Australia. Pneumococcal Study Group. Med J Aust 1999; 170:152-155.
36. Yu VL, Chiou CC, Feldman C et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37:230-237.
37. Ortqvist A, Sterner G, Nilsson AJ. Severe community-acquired pneumonia: factors influencing need for intensive care treatment and prognosis. Scand J Infect Dis 1985; 17:377-386.
38. Spencer RC. Epidemiology of infection in ICUs. Intensive Care Med 1994; 20:S3-S6.
39. Combes A, Figliolini C, Trouillet J-L et al. Incidence and outcome of polymicrobial ventilator associated pneumonia. Chest 2002; 121:1618-1623.
40. Gilbert K, Gleason PP, Singer DE et al. Variations in antimicrobial use and cost in more than 2000 patients with community-acquired pneumonia. Am J Med 1998; 104:17-27.
41. Victorian Drug Usage Advisory Committee. Antibiotic Guidelines Sub-Committee. Antibiotic Guidelines. North Melbourne, Vic.: Victorian Medical Postgraduate Foundation Therapeutics Committee on behalf of the Victorian Drug Usage Advisory Committee, 1996.
42. Fiel S. Guidelines and critical pathways for severe hospital acquired pneumonia. Chest 2001; 119:412S-418S.
43. Mandell LA, Campbell GD. Nosocomial pneumonia guidelines: an international perspective. (Disease management of pulmonary infections). Chest 1998; 113:188S-194S.
44. Malone DC, Shaban HM. Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia. Ann Pharmacother 2001; 35:1180-1185.
45. Menendez R, Ferrando D, Valles JM, Vallterra J. Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest 2002; 122:612-617.
46. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C, and the Canadian Critical Care Trials Group. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999; 159:1234-1256.
47. Papazian L, Bregeon F, Thirion X et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am Journal Respir Crit Care Med 1996; 154:91-97.
48. Ibrahim EH, Tracey L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 2001; 120:555-561.
49. Feldman C, Kallenbach JM, Levy H et al. Community-acquired pneumonia of diverse aetiology: prognosis features in patients admitted to an intensive care unit and a "severity of illness". Intensive Care Med 1989; 15:302-307.
50. Takano Y, Sakamoto M, Suga M, Muranaka H, Ando M. Prognostic factors of nosocomial pneumonia in general wards: a prospective multivariate analysis in Japan. Respir Med 2002; 96:18-23.
51. Greenaway CA, Embil J, Orr PH, McLead J, Dyck B, Nicolle LE. Nosocomial pneumonia on general medical and surgical wards in a tertiary-care hospital. Infect Control Hosp Epidemiol 1997; 18:749-756.
52. Stebbings AE, Ti TY, Tan WC. Hospital acquired pneumonia in the medical intensive care unit: a prospective study. Singapore Med J 1999; 40:508-512.
53. Rello J, Quitana E, Ausina V, Castella J, Luquin M, Prats G. Incidence, etiology and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 1991; 100:439-444.
54. Cunnion KM, Weber DJ, Broadhead WE, Hanson LC, Peiper CF, Rutala WA. Risk factors for nosocomial pneumonia: comparing adult critical care populations. Am J Respir Crit Care Med 1996; 153:358-362.
55. Hill NS. Noninvasive ventilation routine therapy for community-acquired pneumonia? No so fast! Intensive Care Med 2001; 27:797-799.
56. Chassin MR, Brook RH, Park RE et al. Variations in the use of medical and surgical services by Medicare population. N Engl J Med 1986; 314:285-290.
57. Schroeder SA. Strategies for reducing medical costs by changing physicians' behaviour. Int J Technol Assess Health Care 1987; 3:39-50.
58. Moss F, McSwiggan DA, McNicol MW, Miller DL. Survey of prescribing in a district general hospital. Lancet 1981; 2:342-349.
59. Hepler CD, Clyne KE; S.T.D. Rationales expressed by empiric antibiotic prescribers. Am J Hosp Pharm 1982; 39:1647-1655.
60. Fabregas N, Ewig S, Torres A et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54:867-873.